Publication | Closed Access
Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer
12
Citations
0
References
2021
Year
Surgical OncologyOncologyBreast OncologyCancer ManagementBreast CancerCancer TreatmentMedicineRadiation OncologyCancer ResearchEndocrine-related Cancer
No additional data available for this publication yet. Check back later!